BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:17 PM
Oct 01, 2008
 |  BC Extra  |  Clinical News

Idera's IMO-2055 misses RCC endpoint

Idera (NASDAQ:IDRA) said preliminary data from 89 evaluable patients showed that IMO-2055 missed the primary endpoint of tumor response as measured by RECIST...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >